1-13 of 13
Timothy S. Fenske
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Outpatient administration of CAR T-cell therapies using a strategy of no remote monitoring and early CRS intervention

Fateeha Furqan, Vineel Bhatlapenumarthi, Binod Dhakal, Timothy S. Fenske, Faiqa Farrukh, Walter Longo, Othman Akhtar, Anita D’Souza, Marcelo Pasquini, Guru Subramanian Guru Murthy, Lyndsey Runaas, Sameem Abedin, Meera Mohan, Nirav N. Shah, Mehdi Hamadani
Journal: Blood Advances
Blood Adv (2024) 8 (16): 4320–4329.
https://doi.org/10.1182/bloodadvances.2024013239
Published: 2024
Includes: Supplemental data
Journal Articles

CAR T-cell therapy in mantle cell lymphoma with secondary CNS involvement: a multicenter experience

Clinical Trials & Observations
Gulrayz Ahmed, Aseel Alsouqi, Aniko Szabo, Laura Samples, Mazyar Shadman, Farrukh T. Awan, Alexandra E. Rojek, Peter A. Riedell, Madiha Iqbal, Timothy S. Fenske, Mohamed A. Kharfan-Dabaja, Sawa Ito, Mehdi Hamadani
Journal: Blood Advances
Blood Adv (2024) 8 (13): 3528–3531.
https://doi.org/10.1182/bloodadvances.2023012255
Published: 2024
Journal Articles

A phase 1-2 trial of DA-EPOCH-R plus ixazomib for MYC-aberrant lymphoid malignancies: the DACIPHOR regimen

Clinical Trials & Observations
Reem Karmali, Carlos Galvez, Mehdi Hamadani, Leo Gordon, Jane Winter, Shuo Ma, Valerie Nelson, Timothy S. Fenske, Nirav N. Shah, Deepa Jagadeesh, Andreas Klein, Irene Helenowski, Ruohui Chen, Xinlei Mi, Adam Petrich, Andrew M. Evens, Barbara Pro
Journal: Blood Advances
Blood Adv (2024) 8 (7): 1612–1620.
https://doi.org/10.1182/bloodadvances.2023011369
Published: 2024
Includes: Supplemental data
Journal Articles

Salvage polatuzumab and allogeneic transplant rescue patients with B-cell lymphoma failing CAR T-cell therapy

Fateeha Furqan, Morgan Maring, Aniko Szabo, Timothy S. Fenske, Mehdi Hamadani, Nirav N. Shah
Journal: Blood Advances
Blood Adv (2023) 7 (11): 2463–2467.
https://doi.org/10.1182/bloodadvances.2022009025
Published: 2023
Includes: Supplemental data
Journal Articles

Impact of diagnosis to treatment interval in patients with newly diagnosed mantle cell lymphoma

Clinical Trials & Observations
Narendranath Epperla, Jeffrey Switchenko, Veronika Bachanova, James N. Gerson, Stefan K. Barta, Max J. Gordon, Alexey V. Danilov, Natalie S. Grover, Stephanie Mathews, Madelyn Burkart, Reem Karmali, Yazeed Sawalha, Brian T. Hill, Nilanjan Ghosh, Steven I. Park, David A. Bond, Mehdi Hamadani, Timothy S. Fenske, Peter Martin, Mary-Kate Malecek, Brad S. Kahl, Christopher R. Flowers, Brian K. Link, Lawrence D. Kaplan, David J. Inwards, Andrew L. Feldman, Eric D. Hsi, Kami Maddocks, Kristie A. Blum, Nancy L. Bartlett, James R. Cerhan, John P. Leonard, Thomas M. Habermann, Matthew J. Maurer, Jonathon B. Cohen
Journal: Blood Advances
Blood Adv (2023) 7 (11): 2287–2296.
https://doi.org/10.1182/bloodadvances.2022009225
Published: 2023
Includes: Supplemental data
Journal Articles

Integrated safety analysis of umbralisib, a dual PI3Kδ/CK1ε inhibitor, in relapsed/refractory lymphoid malignancies

Clinical Trials & Observations
Matthew S. Davids, Owen A. O’Connor, Wojciech Jurczak, Felipe Samaniego, Timothy S. Fenske, Pier Luigi Zinzani, Manish R. Patel, Nilanjan Ghosh, Bruce D. Cheson, Enrico Derenzini, Danielle M. Brander, James A. Reeves, Wanda Knopińska-Posłuszny, John N. Allan, Tycel Phillips, Paolo F. Caimi, Ewa Lech-Maranda, John M. Burke, Richy Agajanian, Ruth Pettengell, Lori A. Leslie, Chan Y. Cheah, Gustavo Fonseca, James Essell, Julio C. Chavez, John M. Pagel, Jeff P. Sharman, Yanzhi Hsu, Hari P. Miskin, Peter Sportelli, Michael S. Weiss, Ian W. Flinn
Journal: Blood Advances
Blood Adv (2021) 5 (23): 5332–5343.
https://doi.org/10.1182/bloodadvances.2021005132
Published: 2021
Includes: Supplemental data
Journal Articles

Early relapse identifies MCL patients with inferior survival after intensive or less intensive frontline therapy

Clinical Trials & Observations
David A. Bond, Jeffrey M. Switchenko, Diego Villa, Kami Maddocks, Michael Churnetski, Alina S. Gerrie, Subir Goyal, Krithika Shanmugasundaram, Oscar Calzada, Bhaskar Kolla, Veronika Bachanova, James N. Gerson, Stefan K. Barta, Brian T. Hill, Yazeed Sawalha, Peter Martin, Edward Maldonado, Max Gordon, Alexey V. Danilov, Natalie S. Grover, Stephanie Mathews, Madelyn Burkart, Reem Karmali, Nilanjan Ghosh, Steven I. Park, Narendranath Epperla, Talha Badar, Jin Guo, Mehdi Hamadani, Timothy S. Fenske, Mary-Kate Malecek, Brad S. Kahl, Christopher R. Flowers, Kristie A. Blum, Jonathon B. Cohen
Journal: Blood Advances
Blood Adv (2021) 5 (23): 5179–5189.
https://doi.org/10.1182/bloodadvances.2021004765
Published: 2021
Includes: Supplemental data
Journal Articles

Intrathecal chemotherapy for management of steroid-refractory CAR T-cell–associated neurotoxicity syndrome

Clinical Trials & Observations
Nirav N. Shah, Bryon D. Johnson, Timothy S. Fenske, Renju V. Raj, Parameswaran Hari
Journal: Blood Advances
Blood Adv (2020) 4 (10): 2119–2122.
https://doi.org/10.1182/bloodadvances.2020001626
Published: 2020
Journal Articles

Trends in postrelapse survival in classic Hodgkin lymphoma patients after experiencing therapy failure following auto-HCT

Clinical Trials & Observations
Talha Badar, Narendranath Epperla, Aniko Szabo, Steven Borson, John Vaughn, Gemlyn George, Neeraj Saini, Abdul Rashid Shah, Romil D. Patel, Sairah Ahmed, Nirav N. Shah, Amanda F. Cashen, Mehdi Hamadani, Timothy S. Fenske
Journal: Blood Advances
Blood Adv (2020) 4 (1): 47–54.
https://doi.org/10.1182/bloodadvances.2019000736
Published: 2020
Journal Articles

Five-year outcomes of the S1106 study of R-hyper-CVAD vs R-bendamustine in transplant-eligible patients with mantle cell lymphoma

Manali Kamdar, Hongli Li, Robert W. Chen, Lisa M. Rimsza, Michael L. Leblanc, Timothy S. Fenske, Thomas C. Shea, Paul M. Barr, Tycel J. Phillips, John P. Leonard, Brad S. Kahl, Jonathan W. Friedberg, Sonali M. Smith
Journal: Blood Advances
Blood Adv (2019) 3 (20): 3132–3135.
https://doi.org/10.1182/bloodadvances.2019000526
Published: 2019
Journal Articles

Postrelapse survival in diffuse large B-cell lymphoma after therapy failure following autologous transplantation

Clinical Trials & Observations
Narendranath Epperla, Talha Badar, Aniko Szabo, John Vaughn, Steve Borson, Neeraj Y. Saini, Romil D. Patel, Nirav N. Shah, Mehdi Hamadani, Sairah Ahmed, Amanda F. Cashen, Timothy S. Fenske
Journal: Blood Advances
Blood Adv (2019) 3 (11): 1661–1669.
https://doi.org/10.1182/bloodadvances.2019000102
Published: 2019
Includes: Supplemental data
Journal Articles

Outcomes of Medicare-age eligible NHL patients receiving RIC allogeneic transplantation: a CIBMTR analysis

Clinical Trials & Observations
Nirav N. Shah, Kwang Woo Ahn, Carlos Litovich, Timothy S. Fenske, Sairah Ahmed, Minoo Battiwalla, Nelli Bejanyan, Parastoo B. Dahi, Javier Bolaños-Meade, Andy I. Chen, Stefan O. Ciurea, Veronika Bachanova, Zachariah DeFilipp, Narendranath Epperla, Nosha Farhadfar, Alex F. Herrera, Bradley M. Haverkos, Leona Holmberg, Nasheed M. Hossain, Mohamed A. Kharfan-Dabaja, Vaishalee P. Kenkre, Hillard M. Lazarus, Hemant S. Murthy, Taiga Nishihori, Andrew R. Rezvani, Anita D’Souza, Bipin N. Savani, Matthew L. Ulrickson, Edmund K. Waller, Anna Sureda, Sonali M. Smith, Mehdi Hamadani
Journal: Blood Advances
Blood Adv (2018) 2 (8): 933–940.
https://doi.org/10.1182/bloodadvances.2018018531
Published: 2018
Includes: Supplemental data
Journal Articles

Clinicopathologic consensus study of gray zone lymphoma with features intermediate between DLBCL and classical HL

Clinical Trials & Observations
Monika Pilichowska, Stefania Pittaluga, Judith A. Ferry, Jessica Hemminger, Hong Chang, Jennifer A. Kanakry, Laurie H. Sehn, Tatyana Feldman, Jeremy S. Abramson, Athena Kritharis, Francisco J. Hernandez-Ilizaliturri, Izidore S. Lossos, Oliver W. Press, Timothy S. Fenske, Jonathan W. Friedberg, Julie M. Vose, Kristie A. Blum, Deepa Jagadeesh, Bruce Woda, Gaurav K. Gupta, Randy D. Gascoyne, Elaine S. Jaffe, Andrew M. Evens
Journal: Blood Advances
Blood Adv (2017) 1 (26): 2600–2609.
https://doi.org/10.1182/bloodadvances.2017009472
Published: 2017
Includes: Supplemental data